Cargando…
Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab
BACKGROUND: Antibody-dendrimer conjugates have the potential to improve the targeting and release of chemotherapeutic drugs at the tumor site while reducing adverse side effects caused by drug accumulation in healthy tissues. In this study, trastuzumab (TMAB), which binds to human epidermal growth f...
Autores principales: | Ma, Pengkai, Zhang, Xuemei, Ni, Ling, Li, Jinming, Zhang, Fengpu, Wang, Zheng, Lian, Shengnan, Sun, Kaoxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370923/ https://www.ncbi.nlm.nih.gov/pubmed/25834432 http://dx.doi.org/10.2147/IJN.S77152 |
Ejemplares similares
-
Conjugation of Gentamicin to Polyamidoamine Dendrimers Improved Anti-bacterial Properties against Pseudomonas aeruginosa
por: Sheykhloo, Hamed, et al.
Publicado: (2021) -
Second-Generation Polyamidoamine Dendrimer Conjugated with Oligopeptides Can Enhance Plasmid DNA Delivery In Vitro
por: Kim, Seongyeon, et al.
Publicado: (2023) -
Polyamidoamine Dendron-Bearing Lipids as Drug-Delivery Excipients
por: Sarigul, Ender, et al.
Publicado: (2022) -
Potential Use of Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for siRNA
por: Arima, Hidetoshi, et al.
Publicado: (2011) -
Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2‐overexpressing metastatic breast cancer
por: Mukai, Hirofumi, et al.
Publicado: (2016)